Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
In a mouse model of epilepsy, SF0034 led to a 5-fold increase in potency with reduced corrected QT (QTc) liabilities and a more balanced excretion prole compared to Potiga ezogabine. Data were presen...